Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07039357Not ApplicableActive Not Recruiting

Reconfirming the Safety and Performance of the Glyconics-DS System in Known Populations With and Without Diabetes

Role: lead

NCT06261944Not ApplicableActive Not Recruiting

A Pivotal Clinical Investigation Confirming the Safety and Accuracy of the Glyconics-DS in Assessment of Glycated Nail Keratin in Individuals With Unknown Diabetes Status and Performance Evaluation of the Glyconics SW Package

Role: lead

NCT05198895Not ApplicableCompleted

Safety and Performance of the Glyconics-SX System

Role: lead

NCT05476016Not ApplicableCompleted

Safety and Performance of the Glyconics-SX System (ANODE02)

Role: lead

All 4 trials loaded